514 related articles for article (PubMed ID: 12492184)
1. Changing rates of Helicobacter pylori testing and treatment in patients with peptic ulcer disease.
Chiorean MV; Locke GR; Zinsmeister AR; Schleck CD; Melton LJ
Am J Gastroenterol; 2002 Dec; 97(12):3015-22. PubMed ID: 12492184
[TBL] [Abstract][Full Text] [Related]
2. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
[TBL] [Abstract][Full Text] [Related]
4. The quality of care for Medicare patients with peptic ulcer disease.
Ofman JJ; Etchason J; Alexander W; Stevens BR; Herrin J; Cangialose C; Ballard DJ; Bratzler D; Elward KS; FitzGerald D; Culpepper-Morgan J; Marshall B
Am J Gastroenterol; 2000 Jan; 95(1):106-13. PubMed ID: 10638567
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
Gisbert JP; Legido J; García-Sanz I; Pajares JM
Dig Liver Dis; 2004 Feb; 36(2):116-20. PubMed ID: 15002818
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.
Labenz J; Peitz U; Köhl H; Kaiser J; Malfertheiner P; Hackelsberger A; Börsch G
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):110-5. PubMed ID: 10363194
[TBL] [Abstract][Full Text] [Related]
7. Peptic ulcer disease today.
Yuan Y; Padol IT; Hunt RH
Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial.
Schilling D; Demel A; Nüsse T; Weidmann E; Riemann JF
Endoscopy; 2003 May; 35(5):393-6. PubMed ID: 12701009
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of Helicobacter pylori infection among California Medicare patients.
Roll J; Weng A; Newman J
Arch Intern Med; 1997 May; 157(9):994-8. PubMed ID: 9140270
[TBL] [Abstract][Full Text] [Related]
10. Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs.
Quan C; Talley NJ
Am J Gastroenterol; 2002 Dec; 97(12):2950-61. PubMed ID: 12492176
[TBL] [Abstract][Full Text] [Related]
11. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
12. Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: estimating cost-effectiveness using decision analysis.
Fendrick AM; Chernew ME; Hirth RA; Bloom BS
Yale J Biol Med; 1996; 69(2):187-95. PubMed ID: 9112750
[TBL] [Abstract][Full Text] [Related]
13. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
Kearney DJ; Liu CF; Crump C; Brousal A
Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
[TBL] [Abstract][Full Text] [Related]
14. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
15. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
[TBL] [Abstract][Full Text] [Related]
16. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
[TBL] [Abstract][Full Text] [Related]
17. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
[TBL] [Abstract][Full Text] [Related]
18. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
Chan FK
Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Helicobacter pylori in peptic ulcer disease in a Singapore hospital.
Vu C; Ng YY
Singapore Med J; 2000 Oct; 41(10):478-81. PubMed ID: 11281437
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori test-and-treat intervention compared to usual care in primary care patients with suspected peptic ulcer disease in the United States.
Ladabaum U; Fendrick AM; Glidden D; Scheiman JM
Am J Gastroenterol; 2002 Dec; 97(12):3007-14. PubMed ID: 12492183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
